Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $38.13 million. The enterprise value is $64.58 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 52.54 million shares outstanding. The number of shares has increased by 4.10% in one year.
| Current Share Class | 52.54M |
| Shares Outstanding | 52.54M |
| Shares Change (YoY) | +4.10% |
| Shares Change (QoQ) | -2.66% |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 53.62% |
| Float | 51.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| Forward PS | 0.24 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 4.23.
| Current Ratio | 6.49 |
| Quick Ratio | 4.95 |
| Debt / Equity | 4.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.00 |
Financial Efficiency
Return on equity (ROE) is -141.02% and return on invested capital (ROIC) is -31.89%.
| Return on Equity (ROE) | -141.02% |
| Return on Assets (ROA) | -26.83% |
| Return on Capital (ROIC) | -31.89% |
| Revenue Per Employee | $239,019 |
| Profits Per Employee | -$293,621 |
| Employee Count | 480 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, Outset Medical has paid $607,000 in taxes.
| Income Tax | 607,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.94% in the last 52 weeks. The beta is 1.95, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | -85.94% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 51.81 |
| Average Volume (20 Days) | 1,005,657 |
Short Selling Information
The latest short interest is 3.35 million, so 6.37% of the outstanding shares have been sold short.
| Short Interest | 3.35M |
| Short Previous Month | 3.47M |
| Short % of Shares Out | 6.37% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 5.78 |
Income Statement
In the last 12 months, Outset Medical had revenue of $114.73 million and -$140.94 million in losses. Loss per share was -$2.75.
| Revenue | 114.73M |
| Gross Profit | 35.53M |
| Operating Income | -128.87M |
| Pretax Income | -158.67M |
| Net Income | -140.94M |
| EBITDA | -123.10M |
| EBIT | -128.87M |
| Loss Per Share | -$2.75 |
Full Income StatementBalance Sheet
The company has $175.63 million in cash and $202.08 million in debt, giving a net cash position of -$26.45 million or -$0.50 per share.
| Cash & Cash Equivalents | 175.63M |
| Total Debt | 202.08M |
| Net Cash | -26.45M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | 47.82M |
| Book Value Per Share | 0.91 |
| Working Capital | 232.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$124.26 million and capital expenditures -$1.92 million, giving a free cash flow of -$126.18 million.
| Operating Cash Flow | -124.26M |
| Capital Expenditures | -1.92M |
| Free Cash Flow | -126.18M |
| FCF Per Share | -$2.40 |
Full Cash Flow StatementMargins
Gross margin is 30.97%, with operating and profit margins of -112.32% and -122.84%.
| Gross Margin | 30.97% |
| Operating Margin | -112.32% |
| Pretax Margin | -122.32% |
| Profit Margin | -122.84% |
| EBITDA Margin | -107.30% |
| EBIT Margin | -112.32% |
| FCF Margin | -120.25% |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.10% |
| Shareholder Yield | -4.10% |
| Earnings Yield | -369.66% |
| FCF Yield | -330.95% |
Analyst Forecast
The average price target for Outset Medical is $4.38, which is 503.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.38 |
| Price Target Difference | 503.56% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 17.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Outset Medical has an Altman Z-Score of -4.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.76 |
| Piotroski F-Score | 3 |